WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
about
TRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin CortexConcise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetWNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transitionThe prognostic significance of Wnt-5a expression in primary breast cancer is extended to premenopausal women.Overexpression of Wnt5a promotes angiogenesis in NSCLC.Specific extracellular matrix remodeling signature of colon hepatic metastases.The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast CancersInactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2A murine model for the development of melanocytic nevi and their progression to melanoma.Genome wide chromatin occupancy of mrhl RNA and its role in gene regulation in mouse spermatogonial cellsOver-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.Decreased Wnt5a Expression is a Poor Prognostic Factor in Triple-Negative Breast Cancer.Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles.Multiple Roles of WNT5A in Breast Cancer.Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.FOXP3 suppresses breast cancer metastasis through downregulation of CD44.WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells.Molecular genetics and targeted therapy of WNT-related human diseases (Review).Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model.Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates.Association between Wnt inhibitory factor 1 and receptor tyrosine kinase-like orphan receptor 2 protein expression and the clinical pathological significance in benign and malignant pancreatic lesions.Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells.CK1ε and p120-catenin control Ror2 function in non-canonical Wnt signaling.Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
P2860
Q27340453-598509AF-3C53-4EAB-81D7-D236D820829AQ28083115-B7DA4E4C-BD72-4A0D-B195-575C12660B55Q28595799-25821904-48E6-4B08-A788-DADBF708FB73Q31130930-09A13DAD-1603-47F8-9725-9EC9739673F2Q33791918-420F9148-5982-45E1-A0C6-FC38B590B75FQ34984735-272E1594-5BA2-4D56-A9FA-C9D4E7C4E2DDQ35869105-E2B2424D-F8E3-4A8F-884C-3BC2B0FC56AFQ35957843-C17D05E1-60D9-4A41-B7A8-63AC2D524333Q36073207-62FA4079-6154-4224-9F65-94B8C23FE864Q36192050-9A338957-70BE-4893-A2C0-289861B4873BQ36413067-F3E2F42E-8C4D-4BCA-BB4B-6BC75749E1D0Q36429159-2861A3A0-41D3-4BB2-A6D0-9912C6B67103Q37049673-E8C20B63-3967-4884-8479-69069687ACF2Q37420188-9B043BE5-CB1B-41F8-AFF5-EC7F08B194CEQ37545894-C27AD8A2-6B2B-4D7E-870A-24F6DDCB291EQ37676740-B724CE7F-E124-4FC1-B22F-A00E0734FE27Q38909359-05071874-8097-4608-B515-4209D4356CDEQ39144973-36275FF5-30D7-4AE4-A3E9-A25D5CA761E7Q39450241-D0496240-B631-46FF-A20A-3656E5D23E37Q41491922-92BF01DC-A22E-4593-9124-4E024D71BE65Q41497717-25F1D65B-DEE4-4130-B11B-F37319B677ACQ42290641-B0E1B1CB-8599-45C3-8EDC-03F3C2595A7AQ42511518-941FA51B-D847-42D7-9587-11AE75EC68C8Q47107790-879D2048-A88E-4C17-A9CB-3D1C7929F243Q47138678-95CC2492-13C4-487F-A2D0-E3A1F4120A74Q49710345-91EF820C-BFF3-41CF-8336-A2AEF49D13C3Q53435219-E94678F4-D037-4CDE-BAA4-811E5444C2DD
P2860
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@ast
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@en
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@nl
type
label
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@ast
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@en
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@nl
prefLabel
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@ast
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@en
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@nl
P2093
P2860
P1433
P1476
WNT5A inhibits metastasis and alters splicing of Cd44 in breast cancer cells.
@en
P2093
Elizabeth H Mitchell
Michael R Crowley
Philip Sohn
Rosa Serra
P2860
P304
P356
10.1371/JOURNAL.PONE.0058329
P407
P577
2013-03-06T00:00:00Z